Citing funds from Keralty, the parent company of EPS Sanitas, Petro accused senators of succumbing to external financial interests.
However, this accusation prompted a swift response from Congress.
Colombian Congress President Name defended Senate integrity, denouncing Petro’s remarks as unfounded and damaging to parliamentarians’ dignity.
In addition, the dispute highlighted a deepening rift between the executive and legislative branches in Colombia.
Petro, not deterred by legislative resistance, took bold action by intervening in the country’s largest health promoters, aiming to overhaul the healthcare system.
This move, along with his accusations against Congress, signifies a growing conflict with potential implications for Colombia‘s democracy and governance.
Friction between Petro and Name was apparent since Name’s Senate presidency election, symbolizing ideological divergence between legislature and executive.
Petro’s ongoing agenda pushes hint at escalating confrontation with Congress, signaling turbulent times for Colombian politics.